About Devendrakirtipharma
Devendrakirtipharma is a Healthcare company. It produces citrate, zinc, choline salts, and other pharmaceutical chemicals for global markets. It operates on a B2B model in Healthcare and Industrial Goods & Manufacturing sectors. The company has 14 employees. Its Indian entity Devendra Kirti Pharmachem Pvt. Ltd. reported revenue of ₹3.27 Cr. Devendrakirtipharma offers products and services including Ambroxol HCL, Ferric Ammonium Citrate, Zinc Sulphate Hepta Hydrate, Sodium Benzoate, and Citric Acid Anhydrous. Its focus areas include Pharmaceuticals, Chemical Manufacturing, API and Salts and Chemicals.
Company details
Devendra Kirti Pharmachem Pvt. Ltd., established in 1986, specializes in manufacturing a range of pharmaceutical chemicals including citrate salts, zinc salts, choline salts, sodium benzoates, and phosphates. The company operates from its manufacturing unit in Tarapur, Maharashtra, India, adhering to schedule M norms for quality. It supplies these products to various industries, focusing on compliance and innovation in chemical production.
- Employees 14
- SectorsHealthcareIndustrial Goods & Manufacturing
- Email••••••••
- Website devendrakirtipharma.com
- Legal Name Devendra Kirti Pharmachem Pvt. Ltd.
- Date of Incorporation 14 Jul, 1986
- Jurisdiction Palghar, Maharashtra, India
- Indian entity revenue₹3.27 Cr
FY 2024 · -31% YoY
- Indian entity net profit₹1.2 Lakh
FY 2024 · 0% margin
- Indian entity EBITDA₹52.9 Lakh
FY 2024 · 16% margin
- Employee Count14
Associated legal entities of Devendrakirtipharma
Devendrakirtipharma operates through Devendra Kirti Pharmachem Pvt. Ltd. (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Devendra Kirti Pharmachem Pvt. Ltd. CIN U99999MH1986PTC040395 | Active | 14 Jul 1986 | Palghar, Maharashtra | ₹3.3 Cr | 14 | 2 | View details |
Products & Services of Devendrakirtipharma
Devendrakirtipharma offers a comprehensive portfolio of products and services, including Ambroxol HCL, Ferric Ammonium Citrate, Zinc Sulphate Hepta Hydrate, Sodium Benzoate, and Citric Acid Anhydrous.
Active ingredient for respiratory treatments in pharmaceuticals.
Iron compound used in pharmaceuticals and food fortification.
Zinc supplement for industrial and health applications.
Food and pharmaceutical preservative against microbial growth.
Acid used in food, beverages, and pharmaceutical formulations.
Board of directors of Devendra Kirti Pharmachem Pvt. Ltd. (Devendrakirtipharma)
Devendra Kirti Pharmachem Pvt. Ltd. is the primary company behind Devendrakirtipharma. The board of Devendra Kirti Pharmachem Pvt. Ltd. currently have 2 directors; the longest-serving is Abhay Yashwant Chaudhari, appointed in 2011. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Abhay Yashwant Chaudhari DIN 02251502 | Director | 18 Mar 2011 | 15 yrs 7 mo | Devendra Kirti Pharmachem Pvt. Ltd. |
| Kushal Jagdhar Velaskar DIN 07731141 | Director | 16 Dec 2016 | 9 yrs 10 mo | Devendra Kirti Pharmachem Pvt. Ltd. |
Financials of Devendrakirtipharma
Figures of Devendra Kirti Pharmachem Pvt. Ltd., the primary company behind Devendrakirtipharma, for FY 2024. Revenue was ₹3.27 Cr (-31% year on year). Net profit was ₹1.2 Lakh (0% margin). EBITDA was ₹52.9 Lakh (16% margin). Revenue has grown at a compounded annual rate of -9% over three years and -7% over five years.
- ₹3.27 CrRevenue · FY 2024 · -31% YoY
- ₹1.2 LakhNet profit · 0% margin
- ₹52.9 LakhEBITDA · 16% margin
- ₹3.9 LakhPaid-up capital
- 14Employees (provident fund records)
- -9%Revenue CAGR, 3 years
- -7%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Devendra Kirti Pharmachem Pvt. Ltd. are on its company page.
Detailed financial statements for Devendrakirtipharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Devendrakirtipharma
Devendrakirtipharma has 14 employees.
The primary company behind Devendrakirtipharma, Devendra Kirti Pharmachem Pvt. Ltd., reported revenue of ₹3.27 Cr for FY 2024, down 31% year on year.
Devendra Kirti Pharmachem Pvt. Ltd., established in 1986, specializes in manufacturing a range of pharmaceutical chemicals including citrate salts, zinc salts, choline salts, sodium benzoates, and phosphates. The company operates from its manufacturing unit in Tarapur, Maharashtra, India, adhering to schedule M norms for quality. It supplies these products to various industries, focusing on compliance and innovation in chemical production.
Devendrakirtipharma offers Ambroxol HCL, Ferric Ammonium Citrate, Zinc Sulphate Hepta Hydrate, Sodium Benzoate, and Citric Acid Anhydrous.
Devendrakirtipharma operates through Devendra Kirti Pharmachem Pvt. Ltd..
The legal entities of Devendrakirtipharma currently have 2 directors, including Kushal Jagdhar Velaskar, Abhay Yashwant Chaudhari.